HMGB1作为鼻炎性疾病的关键调节器:叙述性审查
Desiderio Passali1, Luisa Maria Bellussi1, Mariaconsiglia Santantonio2
1ENT Clinic, University of Siena, 53100 Siena, SI, Italy.
Journal of clinical medicine
|August 14, 2025
概括
高流动性组盒1 (HMGB1) 是鼻腔炎的关键参与者,影响慢性鼻炎等疾病. 针对HMGB1为这些疾病提供了新的诊断和治疗策略的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 分子生物学分子生物学
背景情况:
- 高流动性组盒1 (HMGB1) 作为与损伤相关的分子模式分子,在各种疾病中调解炎症.
- 本综述重点关注HMGB1在鼻腔炎症疾病中的关键作用,包括慢性鼻炎和过敏鼻炎.
研究的目的:
- 审查当前关于HMGB1在鼻腔炎症疾病中的作用的文献.
- 探索HMGB1作为这些疾病的潜在诊断生物标志物和治疗点.
主要方法:
- 使用PubMed.com进行了全面的文献审查.
- 专注于从2015年起发表的研究.
- 针对性搜索HMGB1在鼻炎性疾病中的作用.
主要成果:
- HMGB1通过多个受体相互作用显著放大和调节炎症反应.
- HMGB1调节细胞因子的产生,表皮-介质酶过渡和组织重塑,特别是在eosinophilic慢性鼻炎中.
- 治疗药物,如甘氨酸和PPAR-γ激动剂,在调节HMGB1活性方面表现有前途.
结论:
- HMGB1是一种有前途的诊断生物标志物,也是鼻炎性疾病的治疗点.
- 需要进一步的翻译研究才能充分理解HMGB1的复杂机制和治疗潜力.
- HMGB1作为一个"煽动性的十字路口"的角色强调了有针对性的调查的必要性.
相关概念视频
Asthma: Pathogenesis and Management
586
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
586
Drugs Used in Upper Respiratory Disorders: Overview
361
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
361
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
459
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
459
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583
Upper Respiratory Drugs: First and Second-Generation Antihistamines
456
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
456


